Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
2.
Int J Mol Sci ; 21(22)2020 Nov 12.
Artículo en Inglés | MEDLINE | ID: mdl-33198186

RESUMEN

Melanin incorporated into keratinocytes plays an important role in photoprotection; however, abnormal melanin accumulation causes hyperpigmentary disorders. To understand the mechanism behind the accumulation of excess melanin in the skin, it is essential to clarify the spatial distribution of melanosomes or melanin in the epidermis. Although several markers have been used to detect melanosomes or melanin, no suitable markers to determine the precise localization of melanin in the epidermis have been reported. In this study, we showed that melanocore-interacting Kif1c-tail (M-INK), a recently developed fluorescent probe for visualizing mature melanosomes, binds to purified melanin in vitro, and applied it for detecting melanin in human skin tissues. Frozen skin sections from different phototypes were co-stained for the hemagglutinin (HA)-tagged M-INK probe and markers of melanocytes or keratinocytes, and a wide distribution of melanin was observed in the epidermis. Analysis of the different skin phototypes indicated that the fluorescent signals of HA-M-INK correlated well with skin color. The reconstruction of three-dimensional images of epidermal sheets enabled us to observe the spatial distribution of melanin in the epidermis. Thus, the HA-M-INK probe is an ideal tool to individually visualize melanin (or melanosome) distribution in melanocytes and in keratinocytes in skin tissues.


Asunto(s)
Melaninas/metabolismo , Melanosomas/metabolismo , Piel/metabolismo , Adolescente , Adulto , Animales , Células COS , Células Cultivadas , Chlorocebus aethiops , Células Epidérmicas/metabolismo , Epidermis/metabolismo , Femenino , Humanos , Hiperpigmentación/metabolismo , Queratinocitos/metabolismo , Melanocitos/metabolismo , Persona de Mediana Edad , Pigmentación de la Piel/fisiología
3.
J Dermatol Sci ; 100(1): 50-57, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-32873425

RESUMEN

BACKGROUND: The skin barrier consists of multiple lipid-enriched layers, which are characterized by lamellar repeated structures within the intercellular space. Sodium lauryl sulfate is a well-known substance that can disrupt the skin barrier. The mechanisms underlying the barrier repair process, especially the influence of topical sodium lauryl sulfate treatment on lipid transport in the barrier recovery phase, remain unresolved. OBJECTIVE: To understand the process of reconstruction of the intercellular lipid layer of the skin after acute barrier disruption by sodium lauryl sulfate treatment in vivo. METHODS: Female hairless mice were treated with 3 % sodium lauryl sulfate. Transepidermal water loss measurement, histopathological analysis, and gene expression analysis were performed from 1 to 288 h after the topical application of sodium lauryl sulfate. Western blot analysis, immunofluorescence staining, and transmission electron microscopy analysis were performed to examine the expression level of ATP-binding cassette, sub-family A, member 12 (ABCA12), and the secretion level of lamellar bodies. RESULTS: We observed rapid hyper-keratinization at the stratum corneum and the subsequent concurrent secretion of lamellar bodies into the intercellular space of the stratum corneum during the process of skin barrier recovery. ABCA12 expression associated with lipid transportation into lamellar bodies was transiently upregulated and observed in multiple layers in the upper epidermis, especially in the stratum granulosum. CONCLUSION: The skin reacts appropriately to maintain its barrier function by first initiating hyper-keratinization and then increasing lamellar body secretion. Activation of ABCA12 is an essential factor for the recovery of skin barrier function.


Asunto(s)
Transportadoras de Casetes de Unión a ATP/metabolismo , Epidermis/metabolismo , Animales , Epidermis/efectos de los fármacos , Epidermis/ultraestructura , Espacio Extracelular/metabolismo , Femenino , Queratinocitos/efectos de los fármacos , Queratinocitos/metabolismo , Queratinocitos/ultraestructura , Metabolismo de los Lípidos/efectos de los fármacos , Ratones , Ratones Pelados , Microscopía Electrónica de Transmisión , Modelos Animales , Permeabilidad/efectos de los fármacos , Dodecil Sulfato de Sodio/toxicidad , Pérdida Insensible de Agua/efectos de los fármacos
4.
J Dermatol ; 45(2): 145-149, 2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-29266358

RESUMEN

Erythropoietic protoporphyria is a genetic disease characterized by sensitivity to sunlight caused by the accumulation of protoporphyrin IX. Photoprotection against ultraviolet A and visible light is necessary for erythropoietic porphyria patients because the absorption spectrum of protoporphyrin IX lies in both ultraviolet A and visible light region. We developed a novel index, in vitro porphyrin protection factor, based on the protoporphyrin IX absorbance spectrum. We also selected appropriate photoprotective products designed according to protoporphyrin IX absorbance. The porphyrin protection factors of a combination of make-up base with a powder as well as with a liquid foundation were significantly higher than those of a conventional sunscreen product, even at a small application dose. An in-use test carried out for 6 months showed that the efficacy of these products was 78.3%, and no adverse reactions were observed. Male subjects preferred liquid foundation, whereas all female subjects used powder foundation. The preference of the subjects could lead to the long-term use of the tested products. In conclusion, this study provided a new approach to improve photoprotection in erythropoietic protoporphyria patients.


Asunto(s)
Trastornos por Fotosensibilidad/prevención & control , Protoporfiria Eritropoyética/terapia , Protoporfirinas/metabolismo , Luz Solar/efectos adversos , Protectores Solares/uso terapéutico , Espectro de Acción , Administración Cutánea , Adolescente , Adulto , Niño , Femenino , Humanos , Masculino , Persona de Mediana Edad , Prioridad del Paciente/estadística & datos numéricos , Trastornos por Fotosensibilidad/etiología , Polvos , Protoporfiria Eritropoyética/sangre , Protoporfiria Eritropoyética/etiología , Protoporfirinas/sangre , Protoporfirinas/química , Factores Sexuales , Factores de Tiempo , Resultado del Tratamiento , Adulto Joven
5.
Int Immunol ; 16(10): 1497-505, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15351784

RESUMEN

When wild-type BALB/c mice were transferred with OVA-specific Th2 cells followed by OVA inhalation, a severe eosinophilia, mucus hypersecretion and airway hyper-responsiveness (AHR) was induced in parallel with a marked elevation of IL-4, IL-5 and IL-13 levels in bronchoalveolar lavage fluid (BALF). However, neither eosinophilia, AHR nor mucus hypersecretion was induced in Th2 cell-transferred STAT6-/- mice. The failure of eosinophilia was not due to the defect of Th2 cytokine production in BALF of STAT6-/- mice transferred with Th2 cells, but because of the defect of STAT6-dependent eotaxin production. Indeed, intranasal administration of eotaxin reconstituted pulmonary eosinophilia but not AHR and mucus hypersecretion in OVA-inhalated STAT6-/- mice. These results initially provided direct evidence that STAT6-dependent eotaxin production is essential for pulmonary eosinophilia. We also dissociated the role of STAT6 for eosinophilia from that for AHR and mucus hypersecretion. Thus, STAT6 also plays a critical role at late phase of Th2-dependent allergy induction.


Asunto(s)
Asma/inmunología , Hiperreactividad Bronquial/inmunología , Eosinofilia/inmunología , Hipersensibilidad/inmunología , Células Th2/inmunología , Transactivadores/deficiencia , Administración Intranasal , Animales , Asma/etiología , Asma/fisiopatología , Hiperreactividad Bronquial/etiología , Hiperreactividad Bronquial/fisiopatología , Líquido del Lavado Bronquioalveolar/citología , Líquido del Lavado Bronquioalveolar/inmunología , Diferenciación Celular , Quimiocina CCL11 , Quimiocinas CC/administración & dosificación , Quimiocinas CC/inmunología , Eosinofilia/etiología , Eosinofilia/fisiopatología , Pulmón/inmunología , Pulmón/patología , Ratones , Moco/metabolismo , Ovalbúmina/efectos adversos , Ovalbúmina/inmunología , Proteínas Recombinantes/administración & dosificación , Proteínas Recombinantes/inmunología , Factor de Transcripción STAT6 , Transactivadores/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA